Promising trial on statin add-in falls flat; studies continue
January 27th, 2008 Posted by: Dr. Dobson
Washington — The Jan. 14 announcement of findings from the Enhance trial, which compared patients on the cholesterol-lowering drug Vytorin — a combination of ezetimibe and simvastatin — with a statin alone, sent shockwaves through the medical community. After all, many physicians viewed this as a promising approach in reducing heart disease risk because the drugs it combined work differently to reduce LDL cholesterol.
Popularity: unranked [?]
Tags: Promising, trial, statin, add-in, falls, studies, continue